More than 600 people tuned into PSNC’s series of webinars
on complying with General Data Protection Regulation (GDPR).
Simon Dukes begins as PSNC’s Chief Executive.
PSNC submits written evidence to MPs about the impact of generic price increases on pharmacy workload.
Category M hits the headlines, as PSNC announces a £15m a
month increase in prices from August 2018.
PSNC negotiates key improvements to the Flu Vaccination Advanced Service, including a payment increase to £9.48.
PSNC’s Community Pharmacy Brexit Forum meets for the first time, bringing together key stakeholders involved in the medicines supply chain to support community pharmacies ahead of the UK’s exit from the EU.
Funding for 2018/19 is agreed, with PSNC preventing a planned cut of £33m and so retaining it at a level of £2.592bn.
More than 1,000 people register for PSNC’s webinar on the introduction of the Falsified Medicines Directive (FMD), which explained how pharmacies’ day-to-day working might be affected.
As concerns around Brexit heightened, PSNC meets with the Chair of the Health Select Committee to discuss concerns about the impact of a no-deal Brexit on medicines supply.
The PSNC website attracts 35,000 visits in one day following a BBC News article on generic medicines shortages, which PSNC contributed to.
PSNC agrees its strategic plan for 2019/20, which includes supporting local service development and establishing a Technology Working Group.
The Pharmacy Minister addresses LPC Chairs and Chief Officers at the National Meeting of LPCs in London.